Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Temsirolimus> ?p ?o. }
Showing items 1 to 69 of
69
with 100 items per page.
- Temsirolimus abstract "Temsirolimus (CCI-779) is an intravenous drug for the treatment of renal cell carcinoma (RCC), developed by Wyeth Pharmaceuticals and approved by the U.S. Food and Drug Administration (FDA) in late May 2007, and was also approved by the European Medicines Agency (EMEA) on November 2007. It is a derivative of sirolimus and is sold as Torisel.".
- Temsirolimus atcPrefix "L01".
- Temsirolimus atcSuffix "XE09".
- Temsirolimus casNumber "162635-04-3".
- Temsirolimus drugbank "DB06287".
- Temsirolimus fdaUniiCode "624KN6GM2T".
- Temsirolimus iupacName "(1R,2R,4S)-4-{(2R)-2-[(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontin-3-yl]propyl}-2-methoxycyclohexyl 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate".
- Temsirolimus pubchem "6918289".
- Temsirolimus thumbnail Temsirolimus2DACS.svg?width=300.
- Temsirolimus wikiPageID "12474443".
- Temsirolimus wikiPageRevisionID "599257874".
- Temsirolimus atcPrefix "L01".
- Temsirolimus atcSuffix "XE09".
- Temsirolimus c "56".
- Temsirolimus casNumber "162635".
- Temsirolimus chembl "1201182".
- Temsirolimus chemspiderid "21468899".
- Temsirolimus drugbank "DB06287".
- Temsirolimus h "87".
- Temsirolimus hasPhotoCollection Temsirolimus.
- Temsirolimus iupacName "-4".
- Temsirolimus kegg "D06068".
- Temsirolimus legalAu "S4".
- Temsirolimus legalCa "Rx-only".
- Temsirolimus legalUk "POM".
- Temsirolimus legalUs "Rx-only".
- Temsirolimus licenceEu "Torisel".
- Temsirolimus licenceUs "Torisel".
- Temsirolimus medlineplus "a607071".
- Temsirolimus molecularWeight "1030.28".
- Temsirolimus n "1".
- Temsirolimus o "16".
- Temsirolimus pregnancyAu "D".
- Temsirolimus pregnancyUs "D".
- Temsirolimus pubchem "6918289".
- Temsirolimus routesOfAdministration "Intravenous".
- Temsirolimus tradename "Torisel".
- Temsirolimus unii "624".
- Temsirolimus verifiedfields "changed".
- Temsirolimus verifiedrevid "409344559".
- Temsirolimus subject Category:Antineoplastic_drugs.
- Temsirolimus subject Category:Macrolides.
- Temsirolimus type Agent114778436.
- Temsirolimus type Antineoplastic102722458.
- Temsirolimus type AntineoplasticDrugs.
- Temsirolimus type CausalAgent100007347.
- Temsirolimus type CytotoxicDrug103157987.
- Temsirolimus type Drug103247620.
- Temsirolimus type Matter100020827.
- Temsirolimus type Medicine103740161.
- Temsirolimus type PhysicalEntity100001930.
- Temsirolimus type Substance100020090.
- Temsirolimus type Drug.
- Temsirolimus type DrugProduct.
- Temsirolimus type FunctionalSubstance.
- Temsirolimus comment "Temsirolimus (CCI-779) is an intravenous drug for the treatment of renal cell carcinoma (RCC), developed by Wyeth Pharmaceuticals and approved by the U.S. Food and Drug Administration (FDA) in late May 2007, and was also approved by the European Medicines Agency (EMEA) on November 2007. It is a derivative of sirolimus and is sold as Torisel.".
- Temsirolimus label "Temsirolimus".
- Temsirolimus label "Temsirolimus".
- Temsirolimus label "Temsyrolimus".
- Temsirolimus sameAs Temsirolimus.
- Temsirolimus sameAs Temsyrolimus.
- Temsirolimus sameAs m.02w7vrw.
- Temsirolimus sameAs Q7699074.
- Temsirolimus sameAs Q7699074.
- Temsirolimus sameAs DB06287.
- Temsirolimus sameAs Temsirolimus.
- Temsirolimus wasDerivedFrom Temsirolimus?oldid=599257874.
- Temsirolimus depiction Temsirolimus2DACS.svg.
- Temsirolimus isPrimaryTopicOf Temsirolimus.